Novo Nordisk gains 7% on Q1 beat: is it too late to buy NVO stock?
Novo Nordisk’s rebound got another lift on Wednesday after the Danish drugmaker delivered a first-quarter beat and showed that its new Wegovy pill is gaining traction faster than Wall Street…
Must Read
Most Popular This Period
Bitcoin Price Reclaims $79,000 as Brent Oil Price Holds Above $108
Bitcoin price reclaimed the $79,000 level as traders weighed improving crypto market structure against continued pressure from elevated Brent crude prices and geopolitical uncertainty.BTC price…
Stock Movers
Follow Us
Novo Nordisk gains 7% on Q1 beat: is it too late to buy NVO stock?
Novo Nordisk’s rebound got another lift on Wednesday after the Danish drugmaker delivered a first-quarter beat and showed that its…
TLT ETF stock forecast as Peter Schiff warns on the US 30-Year Bond yields
The iShares 20-Year Treasury Bond ETF (TLT) dropped sharply on Monday as long-term government bond yields soared. TLT dropped to…
More Latest News
DeLorean Brings Its Iconic IP to Solana
May 4th, 2026 – Miami, Florida For decades, the DeLorean has meant…
Bitcoin Price Reclaims $79,000 as Brent Oil Price Holds Above $108
Bitcoin price reclaimed the $79,000 level as traders weighed improving crypto market…
Capital One Hit With Class Action Lawsuit for Allegedly Canceling Credit Cards and Denying Customers Earned Rewards
Virginia-based lender Capital One is facing accusations of engaging in unfair, unlawful…
Fed split stuns markets as rates held amid war, inflation fears
The Federal Reserve left interest rates unchanged on Wednesday, but an unusually…
